Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Serap Karaarslan"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Investigation of the Roles of Cyclooxygenase-2 and Galectin-3 Expression in the Pathogenesis of Premenopausal Endometrial Polyps
Esin Kasap, Serap Karaarslan, Esra Bahar Gur, Mine Genc, Nur Sahin, Serkan Güclü
J Pathol Transl Med. 2016;50(3):225-230.   Published online April 16, 2016
DOI: https://doi.org/10.4132/jptm.2016.03.08
  • 7,199 View
  • 84 Download
  • 3 Web of Science
  • 4 Crossref
AbstractAbstract PDF
Background
The pathogenesis and etiology of endometrial polyps has not been elucidated. In this study, we aimed to examine the pathogenic mechanisms of endometrial polyp development using immunohistochemistry. We evaluated the expression of galectin-3 and cyclooxgenase-2 (COX-2) during the menstrual cycle in premenopausal women with endometrial polyps or normal endometrium.
Methods
Thirty-one patients with endometrial polyps and 50 healthy control patients were included in this study. The levels of expression of COX-2 and galectin-3 were studied by immunohistochemistry.
Results
The percentage of COX-2–positive cells and the intensity of COX-2 staining in the endometrium did not vary during the menstrual cycle either in the control group or in patients with endometrial polyps. However, expression of galectin-3 was significantly lower in endometrial polyps and during the proliferative phase of the endometrium compared with the secretory phase.
Conclusions
Our data suggests that the pathogenesis of endometrial polyps does not involve expression of COX-2 or galectin-3.

Citations

Citations to this article as recorded by  
  • Research Progress in the Treatment of Endometrial Polyps
    秀芬 蔡
    Advances in Clinical Medicine.2024; 14(01): 1772.     CrossRef
  • ER and COX2 expression in endometrial hyperplasia processes
    Nataliia Tsyndrenko, Mykola Lyndіn, Kateryna Sikora, Andrew Awuah Wireko, Toufik Abdul-Rahman, Nataliia Hyriavenko, Anatolii Romaniuk
    Medicine.2023; 102(33): e34864.     CrossRef
  • Novel microarchitecture of human endometrial glands: implications in endometrial regeneration and pathologies
    Nicola Tempest, Christopher J Hill, Alison Maclean, Kathleen Marston, Simon G Powell, Hannan Al-Lamee, Dharani K Hapangama
    Human Reproduction Update.2022; 28(2): 153.     CrossRef
  • Variances in the Level of COX-2 and iNOS in Different Grades of Endometrial Cancer
    Marcin Oplawski, Konrad Dziobek, Nikola Zmarzły, Beniamin O. Grabarek, Robert Kiełbasiński, Przemysław Kieszkowski, Piotr Januszyk, Karol Talkowski, Michał Schweizer, Piotr Kras, Andrzej Plewka, Dariusz Boroń
    Current Pharmaceutical Biotechnology.2020; 21(1): 52.     CrossRef
Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic Parameters
Serap Karaarslan, Banu Yaman, Hakan Ozturk, Banu Sarsik Kumbaraci
J Pathol Transl Med. 2015;49(5):389-395.   Published online September 15, 2015
DOI: https://doi.org/10.4132/jptm.2015.08.10
  • 7,237 View
  • 47 Download
  • 7 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Background
Parafibromin is a recently defined tumor suppressor gene. The aim of our study was to determine the relationships of parafibromin expression in urothelial carcinomas (UCs) with prognostic parameters and to evaluate the use of parafibromin as a potential marker of UC. Methods: Parafibromin expression was assessed in 49 UC specimens using immunohistochemistry. The correlations between parafibromin expression and clinical and pathologic parameters were investigated. Results: Of the patients, 42 (85.7%) were male, and the mean age was 69.6 ± 8.2 years (range, 54 to 88 years). Morphologically, the UCs were divided into two groups: papillary (n = 27) and non-papillary (n = 22). There were seven low-grade (14.3%) and 42 high-grade (85.7%) tumors. Parafibromin was negative in 13 tumors (26.5%), partially positive in 19 tumors (38.8%), and positive in 17 tumors (34.7%). Parafibromin expression was more negative in UCs from upper urinary locations (n=17) and with muscularis propria invasion (n=28), which was statistically significant (p = .009 and p = .007, respectively). There was no statistically significant relationship between parafibromin expression and gender, age, tumor grade, survival, or disease-free survival. Conclusions: We found that UC cases with parafibromin positivity had less of a tendency to show muscularis propria invasion and were more commonly located in the lower urinary system. These results need to be confirmed with studies based on larger case series.

Citations

Citations to this article as recorded by  
  • The roles of the tumor suppressor parafibromin in cancer
    Hua-chuan Zheng, Hang Xue, Cong-yu Zhang
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta‐analysis based on individual patient data
    Ruizhe Zhu, Zixing Wang, Ya Hu
    Clinical Endocrinology.2020; 92(4): 295.     CrossRef
  • Thein vitroandin vivoeffects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target
    Hua-chuan Zheng, Jia-jie Liu, Jing Li, Ji-cheng Wu, Lei Yang, Gui-feng Zhao, Xin Zhao, Hua-mao Jiang, Ke-qiang Huang, Zhi-jie Li
    Oncotarget.2017; 8(14): 23603.     CrossRef
  • The clinicopathological and prognostic significances of CDC73 expression in cancers: a bioinformatics analysis
    Hua-Chuan Zheng, Bao-Cheng Gong, Shuang Zhao
    Oncotarget.2017; 8(56): 95270.     CrossRef
  • Significance of Parafibromin Expression in Laryngeal Squamous Cell Carcinomas
    Inju Cho, Mija Lee, Sharon Lim, Ran Hong
    Journal of Pathology and Translational Medicine.2016; 50(4): 264.     CrossRef
Brief Case Report
Sclerosing Extramedullary Hematopoietic Tumor Mimicking Intra-abdominal Sarcoma
Serap Karaarslan, Nalan Nese, Guray Oncel, Nazan Ozsan, Taner Akalin, Hasan Kaplan, Filiz Buyukkececi, Mine Hekimgil
J Pathol Transl Med. 2015;49(4):335-338.   Published online June 15, 2015
DOI: https://doi.org/10.4132/jptm.2015.04.22
  • 8,526 View
  • 64 Download
  • 4 Web of Science
  • 2 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Sclerosing Extramedullary Hematopoietic Tumor (SEHT) Mimicking a Malignant Bile Duct Tumor-Case Report and Literature Review
    Sorin Dema, Fulger Lazar, Robert Barna, Amadeus Dobrescu, Alis Liliana Carmen Dema, Oana Popa, Ioana Ionita, Sorina Maria Taban
    Medicina.2021; 57(8): 824.     CrossRef
  • Sclerosing Extramedullary Hematopoietic Tumor: A Case Report
    Dapeng Wang, Eduardo Castro, Arundhati Rao, Christopher Michael McPhaul
    Journal of Investigative Medicine High Impact Case Reports.2020;[Epub]     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP